Overview

Rapamycin in Combination With Low-Dose Aracytin in Elderly Acute Myeloid Leukemia Patients

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
These study is designed to evaluate the tolerability and efficacy of sirolimus (rapamycin) in combination with low-dose aracytin in elderly AML.
Phase:
Phase 2
Details
Lead Sponsor:
University Hospital, Toulouse
Collaborator:
French Innovative Leukemia Organisation
Treatments:
Everolimus
Sirolimus